MedPath

SUNOVION PHARMACEUTICALS INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

102

Active:88
Completed:8

Trial Phases

3 Phases

Phase 1:54
Phase 3:10
Not Applicable:3

Drug Approvals

3

NMPA:3

Drug Approvals

Lurasidone Hydrochloride Tablets

Product Name
罗舒达
Approval Number
国药准字J20190006
Approval Date
Mar 8, 2019
NMPA

Lurasidone Hydrochloride Tablets

Product Name
罗舒达
Approval Number
H20191009
Approval Date
Mar 6, 2019
NMPA

Lurasidone Hydrochloride Tablets

Product Name
罗舒达
Approval Number
H20190021
Approval Date
Jan 24, 2019
NMPA

Clinical Trials

Distribution across different clinical trial phases (67 trials with phase data)• Click on a phase to view related trials

Phase 1
54 (80.6%)
Phase 3
10 (14.9%)
Not Applicable
3 (4.5%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.